Impact of Fibrinogen, Fibrin Thrombi and Thrombin on Cancer Cell Extravasation Using in vitro Microvascular Networks

A bidirectional association exists between metastatic dissemination and the hypercoagulable state associated with many types of Cancer. As such, clinical studies have provided evidence that markers associated with elevated levels of coagulation and fibrinolysis correlate with decreased patient survival. However, elucidating the mechanisms underpinning the effects of different components of the coagulation system on metastasis formation is challenging both in animal models and 2D models lacking the complex cellular interactions necessary to model both thrombosis and metastasis. Here, an in vitro, 3D, microvascular model for observing the formation of fibrin thrombi is described, which is in turn used to study how different aspects of the hypercoagulable state associated with Cancer affect the endothelium. Using this platform, Cancer cells expressing ICAM-1 are shown to form a fibrinogen-dependent bridge and transmigrate through the endothelium more effectively. Cancer cells are also demonstrated to interact with fibrin thrombi, using them to adhere, spread and enhance their extravasation efficiency. Finally, Thrombin is also shown to enhance Cancer cell extravasation. This system presents a physiologically relevant model of fibrin clot formation in the human microvasculature, enabling in-depth investigation of the cellular interactions between Cancer cells and the coagulation system affecting Cancer cell extravasation. This article is protected by copyright. All rights reserved.

cancer; coagulation; fibrin; metastasis; microphysiological system.